摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

β-oxy-β-ethyl-butylamine | 57728-32-2

中文名称
——
中文别名
——
英文名称
β-oxy-β-ethyl-butylamine
英文别名
1-Amino-2-aethyl-butanol-(2);Aminomethyl-diaethyl-carbinol;β-Oxy-β-aethyl-butylamin;3-(Aminomethyl)pentan-3-ol
β-oxy-β-ethyl-butylamine化学式
CAS
57728-32-2
化学式
C6H15NO
mdl
MFCD09907227
分子量
117.191
InChiKey
OFAPYHPFMXHSQJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    8
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    46.2
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] TRIAZINES SUITABLE FOR USE IN FABRIC TREATMENT COMPOSITIONS<br/>[FR] TRIAZINES POUVANT ETRE UTILISEES DANS DES COMPOSITIONS DE TRAITEMENT DE TISSUS
    申请人:UNILEVER PLC
    公开号:WO2005123699A1
    公开(公告)日:2005-12-29
    A water-soluble, triazine-based, non-dye, cellulose cross-linking agent that has a highly flexible linking group between at least two, mono-reactive cross-linking moieties and further hydrophilic or non-hydrophilic substituents, being preferrably represented by the general formula (I): (R1)(X1)T-L1-B-T(X2)(R2) wherein: R1 et R2 are cellulose-unreactive substituent groups on the s-triazine (T) and may be the same or different, X1 and X2 are leaving groups on the s-triazine which are lost on reaction with cellulose and may be the same or different, L1 et L2 are linking groups, an may be the same or different or absent, B is the bridging group comprising or consisting of at least one aliphatic polyoalkylene chain.
    一种水溶性、基于三嗪的、非染料、纤维素交联剂,其在至少两个单反应性交联基团之间具有高度灵活的连接基团,并且进一步具有亲水性或非亲水性取代基,优选由通式(I)表示:(R1)(X1)T-L1-B-T(X2)(R2)其中:R1和R2是三嗪(T)上的纤维素不反应取代基团,可以相同也可以不同,X1和X2是三嗪上的脱离基团,在与纤维素反应时失去,并且可以相同也可以不同,L1和L2是连接基团,可以相同也可以不同或不存在,B是包含或由至少一个脂肪族聚烯烃链组成的桥接基团。
  • [EN] BORONIC ACID DERIVATIVES<br/>[FR] DÉRIVÉS D'ACIDE BORONIQUE
    申请人:MERCK PATENT GMBH
    公开号:WO2016050358A1
    公开(公告)日:2016-04-07
    Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmue disorder or hematological malignancies.
    式(I)的化合物是LMP7的抑制剂,可用于治疗自身免疫性疾病或血液恶性肿瘤,等等。
  • HIV protease inhibiting compounds
    申请人:Flentge Charles A.
    公开号:US20110003827A1
    公开(公告)日:2011-01-06
    A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
    公开了一种具有以下公式的化合物,作为HIV蛋白酶抑制剂。还公开了抑制HIV感染的方法和组合物。
  • [EN] HIV PROTEASE INHIBITING COMPOUNDS<br/>[FR] COMPOSES INHIBITEURS DE LA PROTEASE DU VIH
    申请人:ABBOTT LAB
    公开号:WO2005061487A1
    公开(公告)日:2005-07-07
    A compound of the formula (I) is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
    公开了一种公式(I)的化合物作为HIV蛋白酶抑制剂。还公开了用于抑制HIV感染的方法和组合物。
  • CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS
    申请人:Borriello Manuela
    公开号:US20150087626A1
    公开(公告)日:2015-03-26
    There is described a novel group of cyclic amine derivative compounds, having an EP 4 receptor antagonistic activity and specifically pharmaceutical compounds which are useful for the treatment or alleviation of Prostaglandin E mediated diseases. The present invention therefore relates to novel compounds which are selective antagonists of the EP 4 subtype of PGE 2 receptors with analgesic and antinflammatory activity, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments, inter alia for the treatment or alleviation of Prostaglandin E mediated diseases such as acute and chronic pain, osteoarthritis, inflammation-associated disorder as arthritis, rheumatoid arthritis, cancer, migraine and endometriosis.
    本发明描述了一组新型的环胺衍生物化合物,具有EP4受体拮抗活性,特别是用于治疗或缓解前列腺素E介导的疾病的药物化合物。因此,本发明涉及的是新型化合物,它们是PGE2受体的EP4亚型的选择性拮抗剂,具有镇痛和抗炎活性,其制备过程,包含它们的药物组合物以及它们作为药物的使用,例如用于治疗或缓解急性疼痛、慢性疼痛、骨关节炎、与炎症相关的疾病如关节炎、类风湿性关节炎、癌症、偏头痛和子宫内膜异位症的前列腺素E介导的疾病。
查看更多